F18.98
Inhalant use, unspecified with other inhalant-induced disorders
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F18.98 refers to unspecified inhalant use alongside other inhalant-induced disorders. This classification is used when a person has been involved in inhalant use that causes health problems, but the specific details or substances involved are not fully identified. Inhalant abuse is a significant health concern, especially among adolescents and young adults, as it can lead to both physical and mental health issues. Recognizing the signs and understanding the nature of inhalant use is essential for appropriate medical assessment and intervention.
Causes & Symptoms
Clinical Causes: Experimentation with volatile substances for psychoactive effects Peer pressure or social influences encouraging inhalant use Availability of inhalants such as aerosols, solvents, or gases Underlying mental health conditions leading to substance misuse Lack of awareness about the health risks associated with inhalants
Key Symptoms: Dizziness or lightheadedness Slurred speech Lack of coordination and unsteady gait Nausea or vomiting Behavioral changes such as irritability, euphoria, or confusion Breathing difficulties or chest tightness Sudden mood swings or depression Lack of concentration and memory problems Possible hallucinations or perceptual distortions
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a comprehensive clinical assessment that includes a detailed history of substance use, physical examination, and possibly laboratory tests. Healthcare providers look for signs of inhalant exposure and related health issues. In cases of inhalant-induced disorders, diagnostic criteria include evidence of inhalant use and corresponding physical or psychological effects. Healthcare professionals may also use specific questionnaires or screening tools to evaluate substance involvement and its impact.
Treatment Protocols: Medical monitoring to address acute physical health issues resulting from inhalant use Counseling or psychotherapy, such as cognitive-behavioral therapy (CBT), to address underlying behavioral factors Motivational interviewing to encourage treatment engagement Support groups and peer support programs for ongoing recovery Educational programs to raise awareness about the risks of inhalant use Long-term psychiatric care if mental health conditions are present
Clinical Advice & FAQs
Billing Guidance
Is F18.98 a billable ICD-10 code?
Yes, F18.98 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F18.98?
Clinical documentation must specify the nature of Inhalant use, unspecified with other inhalant-induced disorders and any associated comorbidities for accurate reporting.
Cite this Clinical Reference